BIOEXTRAX AB (85X0) — Cash Flow-to-Debt Ratio
BIOEXTRAX AB (85X0) has a Cash Flow-to-Debt Ratio of 3.63x as of March 2026, meaning its operating cash flow of €7.68 Million could theoretically repay 4% of its total liabilities (€2.11 Million) in one year. For the full cash flow conversion analysis, see cash flow conversion of BIOEXTRAX AB.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BIOEXTRAX AB Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for BIOEXTRAX AB across 5 annual periods. See BIOEXTRAX AB free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Annual Cash Flow-to-Debt Ratio for BIOEXTRAX AB (2021–2025)
Year-by-year debt coverage analysis for BIOEXTRAX AB. Explore reinvestment intensity of BIOEXTRAX AB to see what proportion of operating cash flow is directed to capital expenditures.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -7.41x | €-26.05 Million | €3.51 Million | ▼ -16.0% |
| 2024 | -6.39x | €-18.78 Million | €2.94 Million | ▲ +45.7% |
| 2023 | -11.78x | €-23.31 Million | €1.98 Million | ▼ -311.5% |
| 2022 | -2.86x | €-17.60 Million | €6.15 Million | ▼ -73.6% |
| 2021 | -1.65x | €-8.48 Million | €5.14 Million | — |